Associated Papers
Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas.
Caughey BA et al.
Journal of Gastrointestinal Oncology, 2023
37969845 (PubMed )
Supplement: jgo-14-05-2083-supplementary.pdf
Select a paper to view details